234 related articles for article (PubMed ID: 31648322)
1. Racial disparities in treatment patterns and outcomes among patients with multiple myeloma: a SEER-Medicare analysis.
Ailawadhi S; Parikh K; Abouzaid S; Zhou Z; Tang W; Clancy Z; Cheung C; Zhou ZY; Xie J
Blood Adv; 2019 Oct; 3(20):2986-2994. PubMed ID: 31648322
[TBL] [Abstract][Full Text] [Related]
2. Trends in multiple myeloma presentation, management, cost of care, and outcomes in the Medicare population: A comprehensive look at racial disparities.
Ailawadhi S; Frank RD; Sharma M; Menghani R; Temkit M; Paulus S; Khera N; Hashmi S; Advani P; Swaika A; Paulus A; Aslam N; Sher T; Roy V; Colon-Otero G; Chanan-Khan A
Cancer; 2018 Apr; 124(8):1710-1721. PubMed ID: 29360160
[TBL] [Abstract][Full Text] [Related]
3. Racial disparity in utilization of therapeutic modalities among multiple myeloma patients: a SEER-medicare analysis.
Ailawadhi S; Frank RD; Advani P; Swaika A; Temkit M; Menghani R; Sharma M; Meghji Z; Paulus S; Khera N; Hashmi SK; Paulus A; Kakar TS; Hodge DO; Colibaseanu DT; Vizzini MR; Roy V; Colon-Otero G; Chanan-Khan AA
Cancer Med; 2017 Dec; 6(12):2876-2885. PubMed ID: 29105343
[TBL] [Abstract][Full Text] [Related]
4. Hispanics have the lowest stem cell transplant utilization rate for autologous hematopoietic cell transplantation for multiple myeloma in the United States: A CIBMTR report.
Schriber JR; Hari PN; Ahn KW; Fei M; Costa LJ; Kharfan-Dabaja MA; Angel-Diaz M; Gale RP; Ganguly S; Girnius SK; Hashmi S; Pawarode A; Vesole DH; Wiernik PH; Wirk BM; Marks DI; Nishihori T; Olsson RF; Usmani SZ; Mark TM; Nieto YL; D'Souza A
Cancer; 2017 Aug; 123(16):3141-3149. PubMed ID: 28472539
[TBL] [Abstract][Full Text] [Related]
5. Cost-Effectiveness of Autologous Hematopoietic Stem Cell Transplantation for Elderly Patients with Multiple Myeloma using the Surveillance, Epidemiology, and End Results-Medicare Database.
Shah GL; Winn AN; Lin PJ; Klein A; Sprague KA; Smith HP; Buchsbaum R; Cohen JT; Miller KB; Comenzo R; Parsons SK
Biol Blood Marrow Transplant; 2015 Oct; 21(10):1823-9. PubMed ID: 26033281
[TBL] [Abstract][Full Text] [Related]
6. Multiple myeloma treatment transformed: a population-based study of changes in initial management approaches in the United States.
Warren JL; Harlan LC; Stevens J; Little RF; Abel GA
J Clin Oncol; 2013 Jun; 31(16):1984-9. PubMed ID: 23569317
[TBL] [Abstract][Full Text] [Related]
7. African Americans with translocation t(11;14) have superior survival after autologous hematopoietic cell transplantation for multiple myeloma in comparison with Whites in the United States.
Badar T; Hari P; Dávila O; Fraser R; Wirk B; Dhakal B; Freytes CO; Rodriguez Valdes C; Lee C; Vesole DH; Malek E; Hildebrandt GC; Landau H; Murthy HS; Lazarus HM; Berdeja JG; Meehan KR; Solh M; Diaz MA; Kharfan-Dabaja MA; Callander NS; Farhadfar N; Bashir Q; Kamble RT; Vij R; Munker R; Kyle RA; Chhabra S; Hashmi S; Ganguly S; Jagannath S; Nishihori T; Nieto Y; Kumar S; Shah N; D'Souza A
Cancer; 2021 Jan; 127(1):82-92. PubMed ID: 32966625
[TBL] [Abstract][Full Text] [Related]
8. The impact of race on outcomes of autologous transplantation in patients with multiple myeloma.
Verma PS; Howard RS; Weiss BM
Am J Hematol; 2008 May; 83(5):355-8. PubMed ID: 18186525
[TBL] [Abstract][Full Text] [Related]
9. Outcome disparities in multiple myeloma: a SEER-based comparative analysis of ethnic subgroups.
Ailawadhi S; Aldoss IT; Yang D; Razavi P; Cozen W; Sher T; Chanan-Khan A
Br J Haematol; 2012 Jul; 158(1):91-8. PubMed ID: 22533740
[TBL] [Abstract][Full Text] [Related]
10. Survival Trends in Young Patients With Multiple Myeloma: A Focus on Racial-Ethnic Minorities.
Ailawadhi S; Azzouqa AG; Hodge D; Cochuyt J; Jani P; Ahmed S; Sher T; Roy V; Ailawadhi M; Alegria VR; Manochakian R; Vishnu P; Grover A; Abdulazeez MF; Paulus A; Chanan-Khan A
Clin Lymphoma Myeloma Leuk; 2019 Oct; 19(10):619-623. PubMed ID: 31377212
[TBL] [Abstract][Full Text] [Related]
11. Autologous stem cell transplantation in first remission is associated with better progression-free survival in multiple myeloma.
Aggarwal M; Agrawal N; Yadav N; Verma P; Ahmed R; Mehta P; Kapoor J; Bhurani D
Ann Hematol; 2018 Oct; 97(10):1869-1877. PubMed ID: 29781040
[TBL] [Abstract][Full Text] [Related]
12. Racial/ethnic disparities in access to care and survival for patients with early-stage hepatocellular carcinoma.
Mathur AK; Osborne NH; Lynch RJ; Ghaferi AA; Dimick JB; Sonnenday CJ
Arch Surg; 2010 Dec; 145(12):1158-63. PubMed ID: 21173289
[TBL] [Abstract][Full Text] [Related]
13. Surveillance mammography use after treatment of primary breast cancer and racial disparities in survival.
Nurgalieva ZZ; Franzini L; Morgan R; Vernon SW; Liu CC; Du XL
Med Oncol; 2013 Dec; 30(4):691. PubMed ID: 23975632
[TBL] [Abstract][Full Text] [Related]
14. Racial/ethnic disparities in the adjuvant chemotherapy of locally advanced colon cancer patients.
Zhong X; Guo Z; Gao P; Song Y; Sun J; Chen X; Sun Y; Wang Z
J Surg Res; 2018 Aug; 228():27-34. PubMed ID: 29907221
[TBL] [Abstract][Full Text] [Related]
15. Disparities in Utilization of Autologous Stem Cell Transplantation as Consolidative Therapy for Multiple Myeloma: A Single Institution Retrospective Review.
Lupak O; Xiaoxia H; Xie P; Thanikachalam K; Jabbour-Aida H; Farhan S; Emole J
Clin Lymphoma Myeloma Leuk; 2021 Aug; 21(8):e680-e685. PubMed ID: 34148850
[TBL] [Abstract][Full Text] [Related]
16. Multiple myeloma treatment patterns and clinical outcomes in the Latin America Haemato-Oncology (HOLA) Observational Study, 2008-2016.
de Moraes Hungria VT; Martínez-Baños DM; Peñafiel CR; Miguel CE; Vela-Ojeda J; Remaggi G; Duarte FB; Cao C; Cugliari MS; Santos T; Machnicki G; Fernandez M; Grings M; Ammann EM; Lin JH; Chen YW; Wong YN; Barreyro P
Br J Haematol; 2020 Feb; 188(3):383-393. PubMed ID: 31392724
[TBL] [Abstract][Full Text] [Related]
17. Socioeconomic status is independently associated with overall survival in patients with multiple myeloma.
Fiala MA; Finney JD; Liu J; Stockerl-Goldstein KE; Tomasson MH; Vij R; Wildes TM
Leuk Lymphoma; 2015; 56(9):2643-9. PubMed ID: 25651424
[TBL] [Abstract][Full Text] [Related]
18. Racial disparities in treatment use for multiple myeloma.
Fiala MA; Wildes TM
Cancer; 2017 May; 123(9):1590-1596. PubMed ID: 28085188
[TBL] [Abstract][Full Text] [Related]
19. Racial Disparities in the Utilization and Outcomes of TAVR: TVT Registry Report.
Alkhouli M; Holmes DR; Carroll JD; Li Z; Inohara T; Kosinski AS; Szerlip M; Thourani VH; Mack MJ; Vemulapalli S
JACC Cardiovasc Interv; 2019 May; 12(10):936-948. PubMed ID: 31122351
[TBL] [Abstract][Full Text] [Related]
20. Factors determining utilization of stem cell transplant for initial therapy of multiple myeloma by patient race: exploring intra-racial healthcare disparities.
Ailawadhi S; Adu Y; Frank RD; Das S; Hodge DO; Fernandez A; Flott C; Elliott J; Parrondo R; Sher T; Roy V; Chanan-Khan AA
Blood Cancer J; 2024 May; 14(1):86. PubMed ID: 38806475
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]